{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:36:33Z","timestamp":1791203793276,"version":"4.2.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6908","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T09:54:13Z","timestamp":1420710853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2\u2013MALT1 in MALT lymphoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Zilin","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"McAllister-Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory M.","family":"Hogaboam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo S. J.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"BFncomms6908_CR1","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1038\/sj.onc.1203018","volume":"18","author":"T Akagi","year":"1999","unstructured":"Akagi, T. et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18, 5785\u20135794 (1999).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR2","first-page":"961","volume":"6","author":"AG Uren","year":"2000","unstructured":"Uren, A. G. et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961\u2013967 (2000).","journal-title":"Mol. Cell"},{"key":"BFncomms6908_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri2338","volume":"8","author":"M Thome","year":"2008","unstructured":"Thome, M. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 8, 495\u2013500 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms6908_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ni1561","volume":"9","author":"B Coornaert","year":"2008","unstructured":"Coornaert, B. et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 9, 263\u2013271 (2008).","journal-title":"Nat. Immunol."},{"key":"BFncomms6908_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni0308-231","volume":"9","author":"LM McAllister-Lucas","year":"2008","unstructured":"McAllister-Lucas, L. M. & Lucas, P. C. Finally, MALT1 is a protease!. Nat. Immunol. 9, 231\u2013233 (2008).","journal-title":"Nat. Immunol."},{"key":"BFncomms6908_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni1568","volume":"9","author":"F Rebeaud","year":"2008","unstructured":"Rebeaud, F. et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9, 272\u2013281 (2008).","journal-title":"Nat. Immunol."},{"key":"BFncomms6908_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2013.08.032","volume":"51","author":"Q Qiao","year":"2013","unstructured":"Qiao, Q. et al. Structural architecture of the CARMA1\/Bcl10\/MALT1 signalosome: nucleation-induced filamentous assembly. Mol. Cell 51, 766\u2013779 (2013).","journal-title":"Mol. Cell"},{"key":"BFncomms6908_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ni1493","volume":"8","author":"U Ferch","year":"2007","unstructured":"Ferch, U. et al. MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat. Immunol. 8, 984\u2013991 (2007).","journal-title":"Nat. Immunol."},{"key":"BFncomms6908_CR9","doi-asserted-by":"publisher","first-page":"19012","DOI":"10.1074\/jbc.M009984200","volume":"276","author":"PC Lucas","year":"2001","unstructured":"Lucas, P. C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J. Biol. Chem. 276, 19012\u201319019 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6908_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/BJ20120035","volume":"443","author":"J Hachmann","year":"2012","unstructured":"Hachmann, J. et al. Mechanism and specificity of the human paracaspase MALT1. Biochem. J. 443, 287\u2013295 (2012).","journal-title":"Biochem. J."},{"key":"BFncomms6908_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmb.2012.02.018","volume":"419","author":"C Wiesmann","year":"2012","unstructured":"Wiesmann, C. et al. Structural determinants of MALT1 protease activity. J. Mol. Biol. 419, 4\u201321 (2012).","journal-title":"J. Mol. Biol."},{"key":"BFncomms6908_CR12","doi-asserted-by":"publisher","first-page":"21004","DOI":"10.1073\/pnas.1111708108","volume":"108","author":"JW Yu","year":"2011","unstructured":"Yu, J. W., Jeffrey, P. D., Ha, J. Y., Yang, X. & Shi, Y. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region. Proc. Natl Acad. Sci. USA 108, 21004\u201321009 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR13","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1073\/pnas.1105020108","volume":"108","author":"S Hailfinger","year":"2011","unstructured":"Hailfinger, S. et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc. Natl Acad. Sci. USA 108, 14596\u201314601 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/emboj.2011.85","volume":"30","author":"J Staal","year":"2011","unstructured":"Staal, J. et al. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J. 30, 1742\u20131752 (2011).","journal-title":"EMBO J."},{"key":"BFncomms6908_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","volume":"153","author":"T Uehata","year":"2013","unstructured":"Uehata, T. et al. Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation. Cell 153, 1036\u20131049 (2013).","journal-title":"Cell"},{"key":"BFncomms6908_CR16","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4161\/cc.10.15.16923","volume":"10","author":"S Rosebeck","year":"2011","unstructured":"Rosebeck, S., Rehman, A. O., Lucas, P. C. & McAllister-Lucas, L. M. From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle 10, 2485\u20132496 (2011).","journal-title":"Cell Cycle"},{"key":"BFncomms6908_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1126\/science.1090769","volume":"302","author":"AA Ruefli-Brasse","year":"2003","unstructured":"Ruefli-Brasse, A. A., French, D. M. & Dixit, V. M. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581\u20131584 (2003).","journal-title":"Science"},{"key":"BFncomms6908_CR18","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1073\/pnas.1204127109","volume":"109","author":"C Vicente-Duenas","year":"2012","unstructured":"Vicente-Duenas, C. et al. Expression of MALT1 oncogene in hematopoietic stem\/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc. Natl Acad. Sci. USA 109, 10534\u201310539 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature04687","volume":"441","author":"VN Ngo","year":"2006","unstructured":"Ngo, V. N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106\u2013110 (2006).","journal-title":"Nature"},{"key":"BFncomms6908_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.20091167","volume":"206","author":"U Ferch","year":"2009","unstructured":"Ferch, U. et al. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 206, 2313\u20132320 (2009).","journal-title":"J. Exp. Med."},{"key":"BFncomms6908_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel, D. et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 22, 825\u2013837 (2012).","journal-title":"Cancer Cell"},{"key":"BFncomms6908_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan, L. et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell 22, 812\u2013824 (2012).","journal-title":"Cancer Cell"},{"key":"BFncomms6908_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc1409","volume":"4","author":"PG Isaacson","year":"2004","unstructured":"Isaacson, P. G. & Du, M. Q. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer 4, 644\u2013653 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms6908_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu, H. et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357, 39\u201340 (2001).","journal-title":"Lancet"},{"key":"BFncomms6908_CR25","first-page":"6205","volume":"59","author":"JA Morgan","year":"1999","unstructured":"Morgan, J. A. et al. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res. 59, 6205\u20136213 (1999).","journal-title":"Cancer Res."},{"key":"BFncomms6908_CR26","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm, J. et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601\u20133609 (1999).","journal-title":"Blood"},{"key":"BFncomms6908_CR27","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1053\/gast.2001.25305","volume":"120","author":"T Sugiyama","year":"2001","unstructured":"Sugiyama, T. et al. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 120, 1884\u20131885 (2001).","journal-title":"Gastroenterology"},{"key":"BFncomms6908_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0002-9440(10)64948-6","volume":"156","author":"M Motegi","year":"2000","unstructured":"Motegi, M. et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am. J. Pathol. 156, 807\u2013812 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFncomms6908_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1349-7006.2002.tb01306.x","volume":"93","author":"T Nakamura","year":"2002","unstructured":"Nakamura, T. et al. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J. Cancer Res. 93, 677\u2013684 (2002).","journal-title":"Jpn J. Cancer Res."},{"key":"BFncomms6908_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrm830","volume":"3","author":"GS Salvesen","year":"2002","unstructured":"Salvesen, G. S. & Duckett, C. S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401\u2013410 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms6908_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","volume":"9","author":"Y Shi","year":"2002","unstructured":"Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459\u2013470 (2002).","journal-title":"Mol. Cell"},{"key":"BFncomms6908_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nri3325","volume":"12","author":"P Vandenabeele","year":"2012","unstructured":"Vandenabeele, P. & Bertrand, M. J. The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling. Nat. Rev. Immunol. 12, 833\u2013844 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms6908_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrc2889","volume":"10","author":"M Gyrd-Hansen","year":"2010","unstructured":"Gyrd-Hansen, M. & Meier, P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 10, 561\u2013574 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms6908_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2005.04.012","volume":"7","author":"H Zhou","year":"2005","unstructured":"Zhou, H., Du, M. Q. & Dixit, V. M. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425\u2013431 (2005).","journal-title":"Cancer Cell"},{"key":"BFncomms6908_CR35","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1158\/0008-5472.CAN-03-3677","volume":"64","author":"Y Hosokawa","year":"2004","unstructured":"Hosokawa, Y., Suzuki, H., Suzuki, Y., Takahashi, R. & Seto, M. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res. 64, 3452\u20133457 (2004).","journal-title":"Cancer Res."},{"key":"BFncomms6908_CR36","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1038\/onc.2008.302","volume":"27","author":"EC LaCasse","year":"2008","unstructured":"LaCasse, E. C. et al. IAP-targeted therapies for cancer. Oncogene 27, 6252\u20136275 (2008).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1198946","volume":"331","author":"S Rosebeck","year":"2011","unstructured":"Rosebeck, S. et al. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science 331, 468\u2013472 (2011).","journal-title":"Science"},{"key":"BFncomms6908_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1073\/pnas.0710504105","volume":"105","author":"K Abe","year":"2008","unstructured":"Abe, K. & Takeichi, M. EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc. Natl Acad. Sci. USA 105, 13\u201319 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/35022514","volume":"406","author":"J Chai","year":"2000","unstructured":"Chai, J. et al. Structural and biochemical basis of apoptotic activation by Smac\/DIABLO. Nature 406, 855\u2013862 (2000).","journal-title":"Nature"},{"key":"BFncomms6908_CR40","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.1038\/sj.onc.1203206","volume":"18","author":"RS Maul","year":"1999","unstructured":"Maul, R. S. & Chang, D. D. EPLIN, epithelial protein lost in neoplasm. Oncogene 18, 7838\u20137841 (1999).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12308-008-0020-x","volume":"2","author":"N Anastasov","year":"2009","unstructured":"Anastasov, N. et al. Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J. Hematopathol. 2, 9\u201319 (2009).","journal-title":"J. Hematopathol."},{"key":"BFncomms6908_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-7-71","volume":"7","author":"WG Jiang","year":"2008","unstructured":"Jiang, W. G. et al. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol. Cancer 7, 71 (2008).","journal-title":"Mol. Cancer"},{"key":"BFncomms6908_CR43","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1074\/jbc.M112.438341","volume":"288","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. J. Biol. Chem. 288, 1469\u20131479 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6908_CR44","first-page":"1283","volume":"32","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Sanders, A. J., Zhang, L. & Jiang, W. G. EPLIN-alpha expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome. Anticancer Res. 32, 1283\u20131289 (2012).","journal-title":"Anticancer Res."},{"key":"BFncomms6908_CR45","doi-asserted-by":"publisher","first-page":"19946","DOI":"10.1073\/pnas.0907511106","volume":"106","author":"S Hailfinger","year":"2009","unstructured":"Hailfinger, S. et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl Acad. Sci. USA 106, 19946\u201319951 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR46","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1073\/pnas.88.10.4367","volume":"88","author":"T Boehm","year":"1991","unstructured":"Boehm, T., Foroni, L., Kaneko, Y., Perutz, M. F. & Rabbitts, T. H. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl Acad. Sci. USA 88, 4367\u20134371 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6908_CR47","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1128\/MCB.9.5.2124","volume":"9","author":"EA McGuire","year":"1989","unstructured":"McGuire, E. A. et al. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol. Cell. Biol. 9, 2124\u20132132 (1989).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6908_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/j.1460-2075.1988.tb02825.x","volume":"7","author":"T Boehm","year":"1988","unstructured":"Boehm, T. et al. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J. 7, 385\u2013394 (1988).","journal-title":"EMBO J."},{"key":"BFncomms6908_CR49","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1128\/MCB.12.9.4186","volume":"12","author":"EA McGuire","year":"1992","unstructured":"McGuire, E. A., Rintoul, C. E., Sclar, G. M. & Korsmeyer, S. J. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia\/lymphoma. Mol. Cell. Biol. 12, 4186\u20134196 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6908_CR50","first-page":"2389","volume":"7","author":"P Fisch","year":"1992","unstructured":"Fisch, P. et al. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene 7, 2389\u20132397 (1992).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR51","first-page":"1887","volume":"6","author":"B Royer-Pokora","year":"1991","unstructured":"Royer-Pokora, B., Loos, U. & Ludwig, W. D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6, 1887\u20131893 (1991).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR52","first-page":"577","volume":"6","author":"IS Garcia","year":"1991","unstructured":"Garcia, I. S. et al. A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia. Oncogene 6, 577\u2013582 (1991).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature09609","volume":"469","author":"K Wang","year":"2011","unstructured":"Wang, K. et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469, 216\u2013220 (2011).","journal-title":"Nature"},{"key":"BFncomms6908_CR54","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","volume":"108","author":"P Van Vlierberghe","year":"2006","unstructured":"Van Vlierberghe, P. et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108, 3520\u20133529 (2006).","journal-title":"Blood"},{"key":"BFncomms6908_CR55","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1128\/MCB.23.24.9003-9013.2003","volume":"23","author":"MP McCormack","year":"2003","unstructured":"McCormack, M. P., Forster, A., Drynan, L., Pannell, R. & Rabbitts, T. H. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol. Cell. Biol. 23, 9003\u20139013 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6908_CR56","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1182378","volume":"327","author":"MP McCormack","year":"2010","unstructured":"McCormack, M. P. et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327, 879\u2013883 (2010).","journal-title":"Science"},{"key":"BFncomms6908_CR57","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1182\/blood-2002-10-3236","volume":"101","author":"D Sanchez-Izquierdo","year":"2003","unstructured":"Sanchez-Izquierdo, D. et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101, 4539\u20134546 (2003).","journal-title":"Blood"},{"key":"BFncomms6908_CR58","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1091\/mbc.01-08-0414","volume":"13","author":"Y Song","year":"2002","unstructured":"Song, Y., Maul, R. S., Gerbin, C. S. & Chang, D. D. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton. Mol. Biol. Cell 13, 1408\u20131416 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"BFncomms6908_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-9-60","volume":"9","author":"L Leitner","year":"2010","unstructured":"Leitner, L., Shaposhnikov, D., Descot, A., Hoffmann, R. & Posern, G. Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL\/MRTF coactivators. Mol. Cancer 9, 60 (2010).","journal-title":"Mol. Cancer"},{"key":"BFncomms6908_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/labinvest.2008.18","volume":"88","author":"A Bernheim","year":"2008","unstructured":"Bernheim, A. et al. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab. Invest. 88, 464\u2013473 (2008).","journal-title":"Lab. Invest."},{"key":"BFncomms6908_CR61","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1042\/BC20060126","volume":"99","author":"Q Zheng","year":"2007","unstructured":"Zheng, Q. & Zhao, Y. The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol. Cell 99, 489\u2013502 (2007).","journal-title":"Biol. Cell"},{"key":"BFncomms6908_CR62","first-page":"5296","volume":"60","author":"S Kang","year":"2000","unstructured":"Kang, S. et al. PCD1, a novel gene containing PDZ and LIM domains, is overexpressed in several human cancers. Cancer Res. 60, 5296\u20135302 (2000).","journal-title":"Cancer Res."},{"key":"BFncomms6908_CR63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0168-9525(94)90034-5","volume":"10","author":"I Sanchez-Garcia","year":"1994","unstructured":"Sanchez-Garcia, I. & Rabbitts, T. H. The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet. 10, 315\u2013320 (1994).","journal-title":"Trends Genet."},{"key":"BFncomms6908_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0092-8674(94)90191-0","volume":"79","author":"KL Schmeichel","year":"1994","unstructured":"Schmeichel, K. L. & Beckerle, M. C. The LIM domain is a modular protein-binding interface. Cell 79, 211\u2013219 (1994).","journal-title":"Cell"},{"key":"BFncomms6908_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrc3418","volume":"13","author":"JM Matthews","year":"2013","unstructured":"Matthews, J. M., Lester, K., Joseph, S. & Curtis, D. J. LIM-domain-only proteins in cancer. Nat. Rev. Cancer 13, 111\u2013122 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms6908_CR66","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ccr.2011.04.010","volume":"19","author":"JC Brenner","year":"2011","unstructured":"Brenner, J. C. et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 19, 664\u2013678 (2011).","journal-title":"Cancer Cell"},{"key":"BFncomms6908_CR67","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ncb2463","volume":"14","author":"L Busino","year":"2012","unstructured":"Busino, L. et al. Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat. Cell Biol. 14, 375\u2013385 (2012).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms6908_CR68","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/blood.V97.10.3191","volume":"97","author":"J Theil","year":"2001","unstructured":"Theil, J. et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 97, 3191\u20133196 (2001).","journal-title":"Blood"},{"key":"BFncomms6908_CR69","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1038\/onc.2011.542","volume":"31","author":"SR McDonnell","year":"2012","unstructured":"McDonnell, S. R. et al. NPM-ALK signals through glycogen synthase kinase 3beta to promote oncogenesis. Oncogene 31, 3733\u20133740 (2012).","journal-title":"Oncogene"},{"key":"BFncomms6908_CR70","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1182\/blood-2013-01-482026","volume":"122","author":"SR McDonnell","year":"2013","unstructured":"McDonnell, S. R. et al. Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma. Blood 122, 958\u2013968 (2013).","journal-title":"Blood"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6908","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:20:18Z","timestamp":1672903218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,5]]}},"alternative-id":["BFncomms6908"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6908","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725301283.793504114","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"27 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5908"}}